GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3,113
Frequently Asked Questions
What is Market Cap of GlaxoSmithkline Pharmaceuticals Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. GlaxoSmithkline Pharmaceuticals Ltd market cap is 391.4B.
What is the 52-week high for GlaxoSmithkline Pharmaceuticals Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GlaxoSmithkline Pharmaceuticals Ltd 52 week high is 3,515.70 as of April 05, 2026.
What is the 52-week low for GlaxoSmithkline Pharmaceuticals Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GlaxoSmithkline Pharmaceuticals Ltd 52 week low is 2,217.60 as of April 05, 2026.
What is GlaxoSmithkline Pharmaceuticals Ltd stock price today?
GlaxoSmithkline Pharmaceuticals Ltd stock price today is 2,305.00.
What was GlaxoSmithkline Pharmaceuticals Ltd stock price yesterday?
GlaxoSmithkline Pharmaceuticals Ltd stock price yesterday was 2,322.60.
What is the PE ratio of GlaxoSmithkline Pharmaceuticals Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. GlaxoSmithkline Pharmaceuticals Ltd's P/E ratio is 38.35.
What is the Price-to-Book ratio of GlaxoSmithkline Pharmaceuticals Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. GlaxoSmithkline Pharmaceuticals Ltd P/B ratio is 22.9304.
What is the 50-day moving average of GlaxoSmithkline Pharmaceuticals Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. GlaxoSmithkline Pharmaceuticals Ltd 50-day moving average is 2,462.06.
How many employees does GlaxoSmithkline Pharmaceuticals Ltd have?
GlaxoSmithkline Pharmaceuticals Ltd has 3,113 employees.